Human SRI / Sorcin Protein
CP-22,CP22,SCN,V19
- 100ug (NPP2514) Please inquiry
| Catalog Number | P14547-HNCB |
|---|---|
| Organism Species | Human |
| Host | Baculovirus-Insect Cells |
| Synonyms | CP-22,CP22,SCN,V19 |
| Molecular Weight | The recombinant human SRI consists of 200 amino acids and predicts a molecular mass of 21.8 KDa. It migrates as an approximately 20 KDa band in SDS-PAGE under reducing conditions. |
| predicted N | Gly |
| SDS-PAGE | ![]() |
| Purity | > 90 % as determined by SDS-PAGE |
| Protein Construction | A DNA sequence encoding the human SRI (P30626) (Met1-Val198) was expressed and purified. |
| Bio-activity | |
| Research Area | Signaling |Signal Transduction |Cytoskeleton / ECM |Cell Adhesion |Tight Junctions |
| Formulation | Lyophilized from sterile 20mM Tris, 500mM Nacl, 10% glycerol, pH 7.4. 1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA. |
| Background | Sorcin was originally identified in multidrug-resistant cells. It is a alcium-binding protein. Sorcin modulates excitation-contraction coupling in the heart, contributes to calcium homeostasis in the heart sarcoplasmic reticulum. Sorcin is overexpressed in the multi-drug resistant chinese hamster ovary cell line CHRC5 and a variety of multidrug-resistant tumor cell lines, but overexpression is not a sufficient or necessary condition for the acquisition of the multidrug-resistant phenotype. |
| Reference |

